KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Neogenomics (NEO) over the last 6 years, with Q3 2025 value amounting to $9.0 million.

  • Neogenomics' Change in Acquisitions & Divestments rose 2357.54% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year decrease of 6364.04%. This contributed to the annual value of $53.9 million for FY2024, which is 5195.29% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Change in Acquisitions & Divestments is $9.0 million, which was up 2357.54% from $3.0 million recorded in Q2 2025.
  • Neogenomics' 5-year Change in Acquisitions & Divestments high stood at $40.4 million for Q1 2023, and its period low was $3.0 million during Q2 2025.
  • In the last 5 years, Neogenomics' Change in Acquisitions & Divestments had a median value of $20.1 million in 2024 and averaged $19.3 million.
  • As far as peak fluctuations go, Neogenomics' Change in Acquisitions & Divestments surged by 67393.89% in 2021, and later tumbled by 8528.76% in 2025.
  • Neogenomics' Change in Acquisitions & Divestments (Quarter) stood at $18.2 million in 2021, then soared by 48.64% to $27.1 million in 2022, then dropped by 10.52% to $24.3 million in 2023, then tumbled by 74.72% to $6.1 million in 2024, then soared by 46.77% to $9.0 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $9.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $8.1 million for Q1 2025.